Although the inhibition of CA9 did not affect the basal level of glycolysis, it significantly inhibited the gemcitabine-induced acceleration of extracellular acidification and mitochondrial functions in cancer cells, which was verified in xenografted mice. Here, CA9 is linked to cancer.